Sarepta Therapeutics | Fremdkapital



Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 956K 2025-06
Amgen USD 53.76B 253M 2025-06
Biogen USD 6.28B 1.74B 2025-06
BioMarin Pharmaceutical USD 596.16M 512K 2025-06
Daiichi Sankyo JPY 100.84B 96M 2025-06
Eli Lilly USD 34.18B 319.4M 2025-06
Gilead Sciences USD 22.14B 6M 2025-06
Incyte USD 31.76M 883K 2025-06
Insmed USD 560.95M 567.39M 2025-06
Ionis Pharmaceuticals USD 625.49M 625.22M 2025-06
Moderna USD 32M 3M 2025-06
Neurocrine Biosciences USD 0 0 2024-12
Pfizer USD 57.5B 137M 2025-06
PTC Therapeutics USD 2.13B 1.85B 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.2B 211M 2025-06
Sarepta Therapeutics USD 1.14B 1.17M 2025-06
Tectonic Therapeutic USD 387K 126K 2024-12
Ultragenyx Pharmaceutical USD 782.75M 782.75M 2025-06
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12


Sarepta Therapeutics Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.